Last reviewed · How we verify
Accelerated Recovery for Total Knee Replacement Surgery With Preoperative Intravenous Iron Combined With Human Erythropoietin for Rapid Hematopoietic Mobilization to Prevent Postoperative Anemia: a Multicenter Randomized Controlled Study (Hematoboost)
This study is a randomized, placebo-controlled, multicenter research design to investigate the effectiveness and safety of a single-dose intravenous iron combined with HuEPO hematopoietic mobilization before surgery in patients undergoing unilateral total knee arthroplasty for the first time.
Details
| Lead sponsor | West China Hospital |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 419 |
| Start date | 2023-07 |
| Completion | 2025-06 |
Conditions
- Total Knee Arthroplasty
Interventions
- Ferric Derisomaltose Injection (Monoferric) and Human Erythropoietin Injection (EPIAO)
- Basic Treatment
Primary outcomes
- Hemoglobin concentration — postoperative 14±3 days
Hemoglobin concentration
Countries
China